QC Kinetix National Medical Director Dr. Mitchell Sheinkop is the Keynote Speaker at the International Conference on Stem Cells and Regenerative Medicine
Dr. Mitchell Sheinkop CHARLOTTE, N.C., Nov. 11, 2024 (GLOBE NEWSWIRE) -- QC…
KFSHRCs New US Patent Opens New Frontiers for Breast Cancer Treatment
RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…